Topics

Companies Related to "refuses review Nabriva injectable antibiotic urinary tract infections" [Most Relevant Company Matches] RSS

21:17 EDT 20th September 2019 | BioPortfolio

Here are the most relevant search results for "refuses review Nabriva injectable antibiotic urinary tract infections" found in our extensive corporate database of over 50,000 company records.

Showing "refuses review Nabriva injectable antibiotic urinary tract infections" Companies 1–25 of 846

Extremely Relevant

Rochester Medical

It's all about quality of life for Rochester Medical. The company focuses on urinary incontinence and urinary retention treatment products, including male external catheters and urethral inserts for women. The firm's RELEASE-NF catheter is designed to prevent urinary tract infections. Most of the company's products are made of silicone rather than latex to reduce the risk of allergic reactions. Ro...


Bioharmony Therapeutics, Inc.

Bioharmony Therapeutics, Inc. is an emerging biopharmaceutical company focused on the discovery and development of first-in-class lysin-based antimicrobial therapeutics for patients with multi-drug resistant Gram-negative bacterial infections. In addition to the Acinetobacter lysin, Bioharmony’s portfolio includes a proprietary line-up of lysins for t...

Nabriva Therapeutics

Headquartered in Vienna, Nabriva Therapeutics is engaged in the discovery and development of innovative antibacterial agents addressing unmet medical need in the hospital and community setting. The company has two compounds currently in clinical trials and expects to have a third compound enter clinical trials later this year. The lead compound, BC-3205, is a parenterally and orally available ...


Relevant

IP&MA, Inc

Since 1996, IP&MA has been assisting health care organizations and related industries prevent infectious and other adverse events. IP&MA's professionals have successfully worked with clients to: Decrease the ventilator associated pneumonia rate in intensive care patients by 29%; providing a cost avoidance of over $160,000 per year. Lower the overall nosocomial infection rate for a long term acut...

Ipsat Therapies Oy

Ipsat Therapies Ltd is a Finnish biotechnology company developing its proprietary IPSAT™ (“Intestinal Protection System in Antibiotic Treatment”) family of products for the prevention of hospital infections and antibiotic resistance

AdvanDx, Inc.

AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for identification of pathogens that cause critical infections in hospitalized patients. Our mission is to improve antibiotic decision-making and patient outcomes while limiting unnecessary and inappropriate antibiotic use and reducing healthcare costs.

Solace Therapeutics, Inc.

Solace Therapeutics is an emerging medical device company focused on the development of non-surgical office based treatments for common bladder disorders, such as stress urinary incontinence (SUI), overactive bladder (OAB), male voiding dysfunction and lower urinary tract symptoms (LUTS). Solace is dedicated to improving the patient's quality of life by eliminating side effects typically associate...

Advanced Life Sciences Holdings, Inc.

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza, is a novel oral once-a-day antibiotic in late-stage development for the treatment of respiratory tract infections including CABP and biodefense pathogens inclu...

Pharmaceutica Limited

Pharmaceutica Limited is a privately owned pharmaceutical company founded in March 2003, to discover and develop a new generation of anti-infective drug technologies that combat the increasing problem caused by the rapid evolution of resistance by pathogenic organisms. The company is targeting both human and veterinary applications for its technologies.The initial focus is to find a solution to th...

AdvanDx, Inc

AdvanDx announces that at the recent American Society for Microbiology (ASM) meeting in Orlando, Florida, EVIGENE™ kits for detecting specific antibiotic resistance, virulence, and toxicity markers such as methicillin-resistance, vancomycin-resistance, PVL and TSST-1 in Staphylococcus aureus and enterococci, were launched for research use only in the United States. EVIGENE was officially launch...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II many dreaded infectious diseases such as diphtheria, pneumonia, syphilis, and tuberculosis disappeared almost overnight. However all is not well with the antibiotics story. The bacterial pathogens are f...

GeeWhiz® for Male Urinary Incontinence

Urinary Incontinence Product for men by Leading Edge InnovationsLeading Edge Innovations is the manufacturer of the GeeWhiz® for Male Urinary Incontinence. Merlin Technologies, Inc. is the distributor for the product.Creators of innovative medical products.Our mission Realizing that Male Urinary Incontinence can be a challenging health issue, we strive to develop the best possible alternative to...

GeneraMedix Inc.

GeneraMedix Inc. is a pharmaceutical company offering high quality injectable generic products to the hospital and specialty markets. In addition to its products already marketed, GeneraMedix has a significant number of injectable products under development, as well as a number of products currently under FDA review. Headquartered in Liberty Corner, New Jersey, the company was founded in Ju...

Poiesis Medical LLC

Poiesis Medical LLC creates advanced urinary products that improve patient care. The company’s first product, the Duette urinary drainage system, addresses design issues with standard urinary catheters and the clinical complications associated with them. For more information about the company, visit www.poiesismedical.com or call 877-487-5740.

Appili Therapeutics Inc.

Appili is dedicated to identifying, acquiring and advancing novel therapeutics for infectious disease. The company has two anti-infective programs, ATI-1501 and ATI-1503, in its pipeline. ATI-1501 is a taste-masked treatment for anaerobic infections, including C. difficile. Appili’s second product, ATI-1503, is a novel antibiotic with broad potential ...

National Kidney Foundation

The National Kidney Foundation, with offices throughout the country, is dedicated to preventing and treating kidney and urinary tract diseases, improving the health and well being of individuals and families affected by these diseases and increasing availability of all organs for transplantation. More at www.kidney.org.

Lakewood-Amedex Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

Lakewood-Amedex, Inc.

Lakewood-Amedex is a privately held development-stage biopharmaceutical company with a broad patent portfolio of inventions, including, 24 granted and/or issued patents and 45 patent applications covering its proprietary NuBiotics family of anti-microbial products, proven to be effective against a wide range of bacteria, encompassing antibiotic resistant strains including methicillin-resistant Sta...

NeoTract, Inc.

NeoTract, Inc. is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent device designed to treat lower urinary tract symptoms (LUTS).

Tetraphase Pharmaceuticals

Tetraphase Pharmaceuticals is a clinical-stage life science company with a groundbreaking synthetic chemistry technology platform that has the power to deliver solutions to the global health crisis caused by antibiotic resistance. Since the company’s inception in 2006, Tetraphase has developed a robust antibiotic franchise that offers the potential to ...

TRACT Therapeutics, Inc.

TRACT Therapeutics, Inc. is a clinical-stage biotechnology company developing a novel therapeutic approach to restoring immune balance in transplantation and autoimmune disease. It’s proprietary platform technology, using autologous, polyclonally expanded T-regulatory cells was developed at Northwestern University by pioneer, Joseph R Leventhal, MD, P...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to combat the increasing number of antibiotic-resistant infections worldwide. The Company has two short-term strategic objectives:To identify and formulate proprietary topical Phage preparations from dis...

ViroPharma

At ViroPharma, we are dedicated to transforming the lives of patients through the commercialization of new and important medicines. Our goal is to focus on developing and marketing innovative products addressing unmet medical needs. We are continuing to position ourselves to do just that. We are a pharmaceutical company focused on the development and commercialization of important medicines to a...

Arsanis Inc

Arsanis is committed to the development of monoclonal antibody therapeutics against severe infectious diseases that cannot be controlled with currently available medical treatments. The company’s major focus is on life threatening infections that are caused by antibiotic resistant pathogens, occur in immune compromised patients or are associated with ...

Allecra Therapeutics GmbH

Allecra Therapeutics Allecra is a biopharmaceutical company established in 2013 focussed on the development of novel treatments to combat multi drug-resistant bacterial infections. Allecra’s Mission Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms thereby saving ...


More From BioPortfolio on "refuses review Nabriva injectable antibiotic urinary tract infections"

Quick Search

Corporate Database Quicklinks